Initiation of ivabradine in cardiogenic shock

AIMS: Ivabradine is a selective sinus node inhibitor indicated in patients with symptomatic chronic heart failure on stable guideline‐recommended heart failure therapy including appropriate doses of beta‐blockers. The use in cardiogenic shock remains off label and has been considered a contraindicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Michael H., Howlett, Jonathan G., Sharma, Nakul C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816060/
https://www.ncbi.nlm.nih.gov/pubmed/31332966
http://dx.doi.org/10.1002/ehf2.12499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816060/
https://www.ncbi.nlm.nih.gov/pubmed/31332966
http://dx.doi.org/10.1002/ehf2.12499

Ejemplares similares